BioSpace News Archive

Needle-free devices delivering superior immunogenicity

DYSIS Medical Ltd, the developer of the innovative DYSIS Ultra Colposcope used in cervical cancer screening, announced today the appointment of Darin Hammers as Chief Executive Officer and a member of the board of directors.

Dow joins Circulate Capital and the Ocean Conservancy with investments to keep plastic waste out of the environment

Boston Scientific Corporation (NYSE: BSX) will participate in Citi’s 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York City.

The planning committee for WORLDSymposium is pleased to announce the 2019 preliminary program. Headlining WORLDSymposium 2019 is Danilo A. Tagle, PhD, MS, Associate Director for Special Initiatives, NCATS, NIH, who will receive the 2019 Roscoe O. Brady Award for Innovation and Accomplishment on Tuesday, February 5, 2019.

Church will describe to nation’s health leaders how health information exchanges and networks have overcome the lack of a national patient ID and normalized data standards to achieve accurate patient matching and better interoperability

Swisslog Healthcare exhibits a broad portfolio of transport and pharmacy automation solutions for hospitals and health systems.

New Immunity Capsule Line are Powered by Patented, Clinically Researched Ingredients with a Simplified, Targeted Approach to Immune Health

Bausch Health Companies Inc. announced today that it has entered into an incremental term loan facility amendment (the “Incremental Amendment”) to its credit agreement, pursuant to which Valeant Pharmaceuticals International (“VPI”), a Delaware corporation and a wholly owned indirect subsidiary of the Company, borrowed $1,500,000,000 of new term B loans.

SQI Diagnostics Inc. (“SQI Diagnostics” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and operational results for the fourth quarter and fiscal year ended September 30, 2018 at 5:00 p.m. ET Tuesday, December 11, 2018.